静脉注射免疫球蛋白：治疗自身免疫性大疱性疾病的最新进展。
Intravenous immunoglobulin: recent advances in the treatment of autoimmune bullous diseases.
机构信息
Department of Dermatology, St George Hospital, Sydney, NSW, Australia.
出版信息
G Ital Dermatol Venereol. 2012 Jun;147(3):259-67.
PMID:22648327
Abstract
Autoimmune bullous diseases describes a heterogenous group of diseases with skin and mucosal involvement with varying degrees of mortality. Intravenous immunoglobulin (IVIg) is a specialised treatment used in the management of these AIBD with variable success. This paper outlines the use of IVIg in these diseases.
摘要
自身免疫性大疱性疾病描述了一组具有皮肤和黏膜受累的异质性疾病，其死亡率不同。静脉注射免疫球蛋白（IVIg）是一种用于治疗这些 AIBD 的特殊治疗方法，其疗效不一。本文概述了 IVIg 在这些疾病中的应用。
Zotero 插件